MediXall Group, Inc. Announces Appointments to Medical Advisory Board

Press Release | 02/01/2018

Ft. Lauderdale, Fla., Feb. 01, 2018 (GLOBE NEWSWIRE) — MediXall Group Inc., (OTCQB: MDXL), a technology and innovation-driven organization structured to bring effective change to the U.S. Healthcare Industry, is pleased to announce that the company has added three medical doctors to the Medical Advisory Board and Credentialing Committee. Dr. Winston Marshall, MD, FACC (Denison, TX), Dr. John DeLuca, MD, DC, (Palm Beach, FL), and Dr. Kenneth Janson, MD, FACS (Boca Raton, FL), are published leaders in their fields of expertise as well as practicing physicians.

Michael Swartz, VP of Operations of MediXall Group, said, “We are assembling a team of Advisors that will guide MediXall to provide powerful solutions to the challenges experienced by practitioners, suppliers, and consumers in the Healthcare Industry. Dr. Marshall, Dr. DeLuca, and Dr. Janson are terrific individual leaders with prestigious careers and significant healthcare experience. Each will be a tremendous asset to MediXall as we continue to drive expansion in Florida, begin our nationwide roll-out, and pursue growth opportunities leveraging the strength of our Healthcare Ecosystem. We’ve also made it a priority to fully credential our providers to industry standards and are proud to have three world-class doctors join the team to help us deliver on this priority. We believe that our Healthcare Marketplace Platform should be no different than traditional healthcare in meeting quality of care standards set by the industry and delivering care to patients that they can trust.”

With MediXall’s commitment to promoting the highest level of quality care for its users, practitioners who join the MediXaid Provider Network must undergo a rigorous process called credentialing and only upon approval by the Credentialing Committee will a provider be able to start providing services through our Healthcare Marketplace Platform. The MediXall Credentialing Committee is responsible for reviewing the qualifications of candidates for the MediXaid Provider Network. Members of the Committee hold a Review meeting monthly to evaluate new providers for approval. MediXall is committed to its credentialing and suitability screening of all practitioners on its platform. Management feels strongly this will lead to the public having total confidence when they are comparing apple to apple healthcare providers.

Dr. Winston S. Marshall is an Interventional Cardiology Specialist in Denison, Texas. Dr. Marshall serves as Vice-President and Physician of Interventional Cardiology at Sherman Cardiovascular Care Associates. His Professional Organizations include being a Fellow, American College of Cardiology, an American College of Cardiology Member, a member of the American Medical Association, Texas Medical Association, American Society of Nuclear Cardiology, Grayson County Medical Society and the Dallas County Medical Society. He is an active staff member at the Wilson N. Jones Medical Center in Sherman, Texas where he has held Committee and Leadership Roles.

Dr. John DeLuca is a Diplomate of the American Board of Internal Medicine and the National Board of Chiropractic Examiners, and has obtained certifications in Hyperbaric Medicine, Pain Management, Nutrition, Strength and Conditioning, and Manipulation Under Anesthesia. He is a member of the Age Management Medicine Group, the Institute of Functional Medicine, the American College for the Advancement of Medicine, Hyperbaric and Undersea Medical Society. In addition to Internal and Hyperbaric Medicine, Dr. DeLuca’s professional focus includes maximizing hormone and neurological functioning, Age Management and Regenerative Medicine, Detoxification and Chelation Therapy, Sports Medicine and Weight Loss, as well as promoting Prevention through Personal Lifestyle Medicine.

Dr. Kenneth Janson is a Fellow of the American College of Surgeons, a former US Air Force Surgeon, a Urologic Surgeon and a certified Age Management Physician. He is a member of the Board of Governors, Tulane University School of Medicine, and a frequent featured speaker at Age Management Medical Group National conferences. He has presented at the World Congress on Age Management Medicine on the topics of Decreasing the Risk of Cognitive Decline with Hormone Optimization, and Long Term Use of Testosterone: Balancing the Risks and Rewards in Patients with Cardiovascular Disease, BPH, and Prostate Cancer. Dr. Janson brings his extensive experience in clinical science and evidence-based medicine to the field of age management to provide a comprehensive treatment and prevention program to his patients. He combines the best of traditional medicine with clinically proven, state-of-the-art methods based on the latest techniques and research.

If you would like to preview the MediXall Healthcare Platform, please contact the company.

About MediXall Group, Inc.

MediXall Group is a technology and innovation-driven organization purposefully designed and structured to bring effective change to the U.S. healthcare industry that is actively trading on the OTCQB under the symbol “MDXL.” The Company believes its revolutionary approach will help drive much needed change that it envisions is needed in the current healthcare system. The mission of the MediXall Group is to revolutionize the medical industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective healthcare for the consumer. By approaching the healthcare ecosystem as a whole, MediXall creates, invests and incubates companies that embody its mission statement. MediXall’s first acquisition was MediXaid®, a developing cloud-based software platform that promises to revolutionize the way people purchase healthcare goods and services.

About MediXall Healthcare Platform

The first product MediXall is developing is the MediXall Healthcare Platform, which is on schedule for a first quarter 2018 launch. The MediXall Platform is a new generation healthcare marketplace platform to address the growing need of self-pay and high deductible consumers for greater transparency and price competition in their healthcare costs. With MediXall.com, patient/clients find price transparency and the ability to make informed choices based on price, location and schedule for requested medical products and services. In this era of rapidly increasing deductibles and healthcare costs, the cloud-based MediXall platform is designed to be transformational and disruptive to traditional methods of medical care and provisioning of medical services to the consumer.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company’s current plans and expectations, as well as future results of operations and financial condition. Specifically, the Company’s ability to raise additional capital, execute its business plan and strategy, sustain or increase gross margins, achieve profitability and build shareholder value are forward looking statements. A more extensive listing of risks and factors that may affect the Company’s business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the Company with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact

Michael Swartz, VP of Operations
MediXall Group, Inc.
Phone: (954) 908-3481
Email: mswartz@medixall.com


MediXall Group, Inc. Completes First Phase Launch of Healthcare Platform and Expands Medical Advisory Board and Executive Team

Press Release | 01/16/2018

Ft Lauderdale, FL, Jan. 16, 2018 (GLOBE NEWSWIRE) — MediXall Group Inc., (OTCQB: MDXL), a technology and innovation-driven organization structured to bring effective change to the U.S. Healthcare Industry is pleased to announce that the company executed a limited launch of a working version of its Healthcare Platform in December 2017 to a target market segment in South Florida, and is now preparing a broader-based market rollout for early Q1 2018 based on the data and feedback received during that launch. The market response to the platform, and other related products that were offered, was extremely positive and the company generated significant revenue during that period.

In preparation for the full launch, MediXall Group is currently interviewing several nationally recognized public relations firms and will be engaging one or more of them to manage the marketing outreach and broadcast messaging as the company grows this year.

The Company has now reached a growth point where additional leadership personnel is required for the next phases of expansion, so we are making appointments to the Advisory Board and Executive Team. We will be announcing these appointments as soon as agreements have been finalized.

Over the past 12 months, MediXall Group has built a robust MediXaid Provider Network of healthcare providers in South Florida, which includes licensed and certified diagnostic centers, internists, general practitioners, dentists, psychotherapists, chiropractors, physical therapists and acupuncturists, among others. The MediXaid Provider Network growth has accelerated over that period, surpassing 5000 healthcare providers registered in its Early Adopter Program, several hundred of whom are in process of being formally credentialed and submitted for review and approval by the Credentialing Committee. The exact number may change daily, so conservative approximate figures are presented here.

The MediXall Credentialing Committee is a panel of experienced and respected physicians from a variety of specialties. Members of the Committee are educated as to the credentialing process and have agreed to hold a Review meeting monthly to evaluate new providers for approval. The Medical Director and Committee members will be announced in a future release.

Michael Swartz, VP of Operations of MediXall Group, said, “Since inception we have been committed to delivering a solution that better connect consumers with high-quality healthcare providers and wellness services. We have spent the past year refining our consumer-centric platform, which enables our Provider Network to engage MediXall Platform users with the level of price transparency and digital convenience that consumers have come to expect in every other aspect of their lives.”

If you would like to preview the MediXall Healthcare Platform, please contact the company.


Turnkey Capital Inc. Signs Agreement with Palm Beach Integrative Medicine, Leases Medical Facility and Opens its First Practice that Blends Integrative and Functional Medicine with Medical Cannabis Certification Support and Care

Press Release | 01/19/2018

Ft Lauderdale, FL , Jan. 19, 2018 (GLOBE NEWSWIRE) — Turnkey Capital Inc. (TKCI), today announced it has signed an agreement to acquire Palm Beach Integrative Medicine and has opened its first Integrative and Functional Medicine facility in Fort Lauderdale, FL. Integrative Medicine combines the best of traditional Western medicine with the best of Alternative/Eastern medicine, emphasizing the whole person, considering and treating all aspects of lifestyle. The clinic specializes in Age Management Medicine, Detoxification and Nutrition, Weight Loss, Sports Medicine Rehabilitation & Exercise, IV nutritional therapy, Internal Medicine and medical cannabis certification support and care.

Palm Beach Integrative Medicine’s former Medical Director, Dr. John DeLuca, MD, DC, has been appointed Chief Medical Officer of TKCI’s Integrative and Functional Medicine facility, and will oversee the operations of the clinic. Dr. DeLuca is a Medical Doctor, Diplomate of the American Board of Internal Medicine and the National Board of Chiropractic Examiners, and has obtained certifications in Hyperbaric Medicine, Pain Management, Nutrition, Strength and Conditioning, and Manipulation Under Anesthesia. He is a member of the Age Management Medicine Group, the Institute of Functional Medicine, the American College for the Advancement of Medicine, the American College of Physicians, and the American College of Sports Medicine.

Dr. DeLuca is also a Chiropractic Physician, board certified in the areas of Pain Management, Chiropractic Sports Care, and Clinical Nutrition. Dr. DeLuca is a graduate of the Acupuncture For Physicians program from UCLA.

Turnkey Capital CEO, Neil Swartz, stated, “Our research has shown that the integration of medical cannabis into an integrative and functional medicine treatment program has proven to be remarkably successful in addressing patient needs and eroding the negative stigmas that surround cannabis. Dr. DeLuca’s combined experience as a medical doctor and an integrative medicine physician provides the exact combination of expertise required to direct this medical center.”

“It is our goal to build a successful and repeatable Integrative and Functional Medicine medical facility and health system model that is distinguished by the ability to combine alternative practices into a patient-centered and data-driven approach that promotes optimal wellness and delivers comprehensive treatment options to our patient community,” added Swartz.

About Turnkey Capital Inc.

Turnkey Capital Inc. (TKCI) is a business advisory company that aligns with, and builds value in, both private, public, and development-stage companies. TKCI plays an active role in developing the strategic direction of our client companies which include: defining short and long-term strategic goals; identifying and planning for the critical success factors to reach these goals; identifying and addressing the challenges and operational improvements required to achieve the critical success factors and, ultimately, the strategic goals.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company’s current plans and expectations, as well as future results of operations and financial condition. Specifically, the Company’s ability to raise additional capital, execute its business plan and strategy, sustain or increase gross margins, achieve profitability and build shareholder value are forward looking statements. A more extensive listing of risks and factors that may affect the Company’s business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the Company with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
Sharon Ford
VP of Operations
Turnkey Capital Inc.
954-440-4678


MediXall Group, Inc. Completes Milestones, Looks To Launch MediXaid Platform and Expand Sales & Marketing

FT LAUDERDALE, FL–(Marketwired – Nov 14, 2017) – MediXall Group Inc. (OTCQB: MDXL) announced today that several significant milestones have been completed. The Company, which initially targeted the South Florida region, will be the first platform of its kind to address the need for consumer-facing healthcare technology and pricing transparency at a level that meets and exceeds regulatory and professional standards, while offering a familiar and convenient user experience, setting MediXaid.com apart from all others.

Since inception, MediXall Group and the development team have finalized the MediXaid Healthcare Platform’s User Interface and User Experience (see demo at http://medixaid.com/demo/) and are currently onboarding MRI centers and Chiropractors to the platform, on track for a soft launch with those specialties in Q4 of 2017.

The MediXaid Provider Network’s 4,000+ registered healthcare providers are continuing to complete their legal agreements and the subsequent process of credentialing and onboarding to the MediXaid Platform. The full launch of the MediXaid Healthcare Platform with all medical services available is on track for the first quarter of 2018, including, but not limited to, the following general categories:

  • Physician services including cosmetic services and surgery
  • Dental services including orthodontics, endodontics, and oral surgery, and other physician services
  • Diagnostic services including MRI, MRA, CT Scan, Stress Tests, sonograms and ultrasounds
  • Laboratory services
  • Home healthcare services

MediXall Group deploys a direct sales approach driven by an inside sales team based in Fort Lauderdale, Florida, and Orlando, Florida. The sales team qualifies and manages prospective and current MediXaid Network Providers, aiming to initiate, retain, and expand their use of the platform over time. The sales team partners with the technology team to provide consultation and product demonstration to prospects to accelerate the onboarding of new subscribers. MediXall Group will begin to engage large companies that have healthcare plans for their employees in the first quarter of 2018. MediXall intends to develop and expand a field sales team responsible for discovery, qualification, and account management for larger organizations.

The MediXaid Platform is creating a unified online environment that connects physicians and caregivers to patients, and payers to the caregivers, across all healthcare settings. Starting with pricing transparency, we intend to expand our service offerings to enable smarter care and empower the customer/patient at virtually every point of the healthcare continuum; whether organically, through acquisitions, or through integration with our strategic partners’ solutions. As we expand the Healthcare EcoSystemTM, the MediXaid Healthcare Platform will facilitate such transformation in the future of healthcare by offering community connectivity, interoperability, data analytics, and consumer engagement features and functionality.

MediXall Group CEO, Neil Swartz, stated, “MediXall has put together a very ambitious expansion strategy that we feel is well supported by our operations history so far. The momentum we are building in the marketplace is only going to grow, and we are adding staff and other regional offices to meet this tremendous challenge.”


MediXall Group, Inc. Announces Formation of an Advisory Board and Its First Appointment

MediXall welcomes its first Advisory Board member – a seasoned business & government administrator brings decades of experience.

(Fort Lauderdale, FL, February 1, 2017) (Marketwired) MediXall Group, Inc., (“MediXall”), is a technology and innovation-driven organization structured to bring effective change to the U.S. healthcare industry.

MediXall Group, Inc. is pleased to announce the formation of an Advisory Board that will be comprised of healthcare industry professionals, vendors/suppliers, and consumers. The Advisory Board will provide MediXall with knowledge, guidance and advice in key areas that complement the array of technologies envisioned by MediXall. In the formation of the Advisory Board MediXall is pleased to announce the appointment of the first Advisory Board member, Mr. Scott Herman.

For more than twenty years Scott Herman has held both appointed and elected governmental positions, including Education, Transportation, Health Services, Economic Development, and Small Business commissions, as well as the U.S. Small Business Advisory Council under House Speaker, Newt Gingrich. As a former member of the U.S. Armed Forces where he served in combat and non-combat roles, Mr. Herman earned numerous awards, including an Army Commendation Medal, Army Achievement Medal, and a Southwest Asia Service Medal. Now living as a combat-disabled veteran, he is uniquely qualified to advise on issues related to veterans and individuals living with disabilities.

“We are assembling a team of Advisors that will guide MediXall to provide powerful solutions to the challenges experienced by practitioners, suppliers, and consumers in the Healthcare Industry,” stated Noel Guillama, Chairman of MediXall Group, Inc.  “We are very pleased to welcome Scott Herman to our Advisory Board, as he brings decades of experience as both a government and business administrator, plus expertise in the field of veteran’s health and the needs of those living with disabilities.”

“I welcome the opportunity to be a part of the MediXall Group, Advisory Board. I am looking forward to providing my expertise and knowledge to a company that is dedicated to creating technological solutions that will empower patients and the healthcare industry to offer better services and equipment, at reduced costs, with greater transparency. This makes the industry stronger for everyone,” stated Scott Herman.

MediXall’s first acquisition, the MediXaid™ platform, is a cloud-based healthcare marketplace portal that will provide customer/patients and healthcare professionals with information about what resources are available for their needs, and empower them to better manage their own wellness. MediXaid promises to be a true disruptor in the healthcare industry and will begin a trend toward healthcare cost containment and reduction.